Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

T-Cell Reconstitution after Unrelated Donor HSCT Using Immunotherapy with CD25/71 Allodepleted Donor T Cells: Results of the Randomised Icat Study

Blood (2019) 134 (Supplement_1): 1995.

https://doi.org/10.1182/blood-2019-124404

Published: 2019

Journal Articles

Absence of Damaging Effects of Stem Cell Donation in Unrelated Donors Assessed By FISH and Gene Variance Screening

Elisabeth P. Nacheva, MD PhD, Trudy Ahyee, C Navarette, Juanah Addada, MDPhDFRCP, Rachel Pawson, Richard Syzdlo, PhD, Stephen Mackinnon, MD, Bronwen E. Shaw, MD PhD, J. Alejandro Madrigal, MDPhDDSc,FRCP,FRCPath

Blood (2019) 134 (Supplement_1): 4474.

https://doi.org/10.1182/blood-2019-131931

Published: 2019

Journal Articles

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency

Blood (2018) 131 (8): 917–931.

https://doi.org/10.1182/blood-2017-09-807487

Published: 2018

Journal Articles

Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Charalampia Kyriakou, Ariane Boumendil, PhD, Herve Finel, Norbert Schmitz, MD, PhD, Henrik Sengeloev, MD, Stephen Mackinnon, MD, Didier Blaise, MD PhD, Patrice Chevallier, MD PhD, Paul Browne, MD, Charles Craddock, MD PhD, Dietger W. Niederwieser, MD, Johannes Schetelig, MD PhD, Stig Lenhoff, Nathalie Fegueux, MD, Silvia Montoto, MD, Peter Dreger, MD PhD

Blood (2016) 128 (22): 4661.

https://doi.org/10.1182/blood.V128.22.4661.4661

Published: 2016

Journal Articles

Successful Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adults with Inherited Primary Immunodeficiency (PID)

Emma C Morris, MD PhD, Thomas Andrew Fox, MRCP, Siobhan Burns, MD PhD, Ben Carpenter, MD, Kirsty J Thomson, MD, David Lowe, MD PhD, Adele K. Fielding, MB BS, PhD FRCP, FRCPath, Karl S Peggs, MD, Panagiotis Kottaridis, FRCPath, PhD MSc, Victoria Grandage, FRCPath, MRCP, PhD, Shari Denovan, RN, Sarah Grace, RN, Julia Dahlstrom, RN, Sarita Workman, RN, Andrew Symes, RN, Stephen Mackinnon, MD, Ronjon Chakraverty, BMBS, PhD, Rachael Hough, MD BMBS, FRCP, FRCPath

Blood (2016) 128 (22): 4681.

https://doi.org/10.1182/blood.V128.22.4681.4681

Published: 2016

Journal Articles

Hepatitis E Viraemia in Transplant Recipients

Reekie Ian, Thomas Fox, Dianne Irish, Tehmina Bharucha, Douglas Thorburn, Harber Mark, Stephen Mackinnon, Tedder Richard, Samreen Ijaz, Mallika Sekhar, MBBS, MDFRCPath, FRCP

Blood (2016) 128 (22): 3846.

https://doi.org/10.1182/blood.V128.22.3846.3846

Published: 2016

Journal Articles

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

Blood (2015) 126 (23): 4399.

https://doi.org/10.1182/blood.V126.23.4399.4399

Published: 2015

Journal Articles

CMV promotes recipient T-cell immunity following reduced-intensity T-cell–depleted HSCT, significantly modulating chimerism status

Rob S. Sellar, Frederick Arce Vargas, Jake Y. Henry, Stephanie Verfuerth, Sarah Charrot, Brendan Beaton, Ronjon Chakraverty, Sergio A. Quezada, Stephen Mackinnon, Kirsty J. Thomson, Karl S. Peggs

Blood (2015) 125 (4): 731–739.

https://doi.org/10.1182/blood-2014-07-589150

Published: 2015

Includes: Supplemental data

Journal Articles

Functional and Genetic Heterogeneity of Distinct Leukemic Stem Cell Populations in CD34- Human Acute Myeloid Leukemia

Blood (2014) 124 (21): 15.

https://doi.org/10.1182/blood.V124.21.15.15

Published: 2014

Journal Articles

Patient/Donor CMV Matching Is a Critical Determinant of Survival in Unrelated Donor Haematopoietic Stem Cell Transplantation

Bronwen E. Shaw, PhD MRCP, FRCPath, Neema P Mayor, Szydlo Richard, Will P Bultitude, Kirkland Keiren, Perry Julia, Wilson Marie, Andrew Clark, Stephen Mackinnon, David I Marks, Antonio Pagliuca, MD FRCP, FRCPath, Michael Potter, PhD, Nigel Russell, Kirsty Thomson, J. Alejandro Madrigal, MD PhD, Steven GE Marsh, PhD

Blood (2014) 124 (21): 1207.

https://doi.org/10.1182/blood.V124.21.1207.1207

Published: 2014

Journal Articles

Pre-Transplantation FDG-PET Predicts Early but Not Late Survival Outcomes Following Allogeneic Transplantation in Chemo-Sensitive Hodgkin Lymphoma

Yasmin Reyal, Irfan Kayani, Ronjon Chakraverty, Adrian Bloor, PhD FRCPath, Christopher P Fox, Kirsty Thomson, Adele K. Fielding, Ben Taylor, Mark Bishton, Emma Morris, Nigel Russell, Stephen Mackinnon, Karl S Peggs

Blood (2014) 124 (21): 1225.

https://doi.org/10.1182/blood.V124.21.1225.1225

Published: 2014

Journal Articles

Cytomegalovirus Drives Mixed Chimerism Following T-Cell Depleted Allogeneic HSCT, Providing Protective Immunity In The Absence Of GvHD

Rob S Sellar, MBBS, Frederick Arce Vargas, PhD, Jake Henry, Simon Thomas, PhD, Alka Stansfield, Stephanie Verfuerth, PhD, Sarah C Charrot, MBBS, Rachael E Hough, MD, Sergio A Quezada, PhD, Kirsty J Thomson, MD, Stephen Mackinnon, MD, Karl S Peggs, MD

Blood (2013) 122 (21): 4524.

https://doi.org/10.1182/blood.V122.21.4524.4524

Published: 2013

Journal Articles

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Kile Green, BSc(Hons), Rob Sellar, MD, Laura Jardine, MD, Janice Ward, Paul Ferguson, MD, Pip Nicolson, MD, Kim Pearce, PhD, Venetia Bigley, MD, PhD, Graham Jackson, MD, Sandeep Nagra, MD, Anne M Dickinson, PhD, Kirsty Thomson, MD, Stephen Mackinnon, MD, Charles Craddock, MD, Matthew P. Collin, MD, PhD, Karl S Peggs, MD

Blood (2013) 122 (21): 4540.

https://doi.org/10.1182/blood.V122.21.4540.4540

Published: 2013

Journal Articles

Donor Attrition At The Confirmatory Typing Stage Results In Poorer Transplant Options For Patients Of All Ethnicities

Robert N Lown, MD, Steven GE Marsh, PhD, Helen Blake, BSc, Irina Evseeva, PhD, Stephen Mackinnon, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Michael N Potter, MBBS, PhD, Nigel H. Russell, MD, Charles Craddock, MD DPhil, J. Alejandro Madrigal, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath

Blood (2013) 122 (21): 3377.

https://doi.org/10.1182/blood.V122.21.3377.3377

Published: 2013

Journal Articles

Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants

Robert N Lown, MD, Steven GE Marsh, PhD, Helen Blake, BSc, Sergio Querol, MD, PhD, Irina Evseeva, PhD, Stephen Mackinnon, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Michael Potter, MD PhD, Nigel Russell, MD, Charles Craddock, MD DPhil, J. Alejandro Madrigal, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath

Blood (2013) 122 (21): 2138.

https://doi.org/10.1182/blood.V122.21.2138.2138

Published: 2013

Journal Articles

CMV-specific cellular therapy for acute myeloid leukemia?

Kirsty J. Thomson, Stephen Mackinnon, Karl S. Peggs

Blood (2012) 119 (4): 1088–1090.

https://doi.org/10.1182/blood-2011-10-383943

Published: 2012

Journal Articles

Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML

Panagiotis Kottaridis, MD, PhD, Maria Tsirogianni, MD, Janet North, BSc, MSc, Chloe Marden, PhD, Stephen Mackinnon, MD, Mark W Lowdell, PhD, FRCPath

Blood (2011) 118 (21): 946.

https://doi.org/10.1182/blood.V118.21.946.946

Published: 2011

Journal Articles

Positive Pre-Transplantation [18-F] FDG-PET Is Not a Barrier to Successful Allograft Outcomes in Chemosensitive Hodgkin Lymphoma

Karl S Peggs, Irfan Kayani, Kirsty Thomson, Emma Morris, MD, Panagiotis Kottaridis, Kirit M Ardeshna, MD, Adele Fielding, Rachael Hough, Anthony H Goldstone, MD, Ronjon Chakraverty, David C Linch, MD FMedSci, Stephen Mackinnon

Blood (2011) 118 (21): 2016.

https://doi.org/10.1182/blood.V118.21.2016.2016

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia:A Study of the British Society for Blood and Marrow Transplantation,

Gordon Cook, Keiren Kirkland, Julia Lee, Rachel M Pearce, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Richard E. Clark, MD, Stephen Mackinnon, MD, David I. Marks, MBBS, PHD

Blood (2011) 118 (21): 4125.

https://doi.org/10.1182/blood.V118.21.4125.4125

Published: 2011

Journal Articles

A Simple Prognostic Score to Predict Short and Long-Term Survival Following ICU Admission in Critically Ill Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: Improved Survival Following Reduced Intensity Conditioning

William Townsend, Ailsa Holroyd, Rachel M Pearce, Stephen Mackinnon, MD, Anthony H. Goldstone, FRCP, FRCPath, David C Linch, MD FMedSci, Karl S Peggs, MD, Kirsty Thomson, MD, Mervyn Singer, Prakesh Naik, David Howell, Emma Morris, MD

Blood (2011) 118 (21): 146.

https://doi.org/10.1182/blood.V118.21.146.146

Published: 2011

NARROW

T-Cell Reconstitution after Unrelated Donor HSCT Using Immunotherapy with CD25/71 Allodepleted Donor T Cells: Results of the Randomised Icat Study

Absence of Damaging Effects of Stem Cell Donation in Unrelated Donors Assessed By FISH and Gene Variance Screening

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency

Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Successful Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adults with Inherited Primary Immunodeficiency (PID)

Hepatitis E Viraemia in Transplant Recipients

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

CMV promotes recipient T-cell immunity following reduced-intensity T-cell–depleted HSCT, significantly modulating chimerism status

Functional and Genetic Heterogeneity of Distinct Leukemic Stem Cell Populations in CD34- Human Acute Myeloid Leukemia

Patient/Donor CMV Matching Is a Critical Determinant of Survival in Unrelated Donor Haematopoietic Stem Cell Transplantation

Pre-Transplantation FDG-PET Predicts Early but Not Late Survival Outcomes Following Allogeneic Transplantation in Chemo-Sensitive Hodgkin Lymphoma

Cytomegalovirus Drives Mixed Chimerism Following T-Cell Depleted Allogeneic HSCT, Providing Protective Immunity In The Absence Of GvHD

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Donor Attrition At The Confirmatory Typing Stage Results In Poorer Transplant Options For Patients Of All Ethnicities

Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants

CMV-specific cellular therapy for acute myeloid leukemia?

Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML

Positive Pre-Transplantation [18-F] FDG-PET Is Not a Barrier to Successful Allograft Outcomes in Chemosensitive Hodgkin Lymphoma

Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia:A Study of the British Society for Blood and Marrow Transplantation,

A Simple Prognostic Score to Predict Short and Long-Term Survival Following ICU Admission in Critically Ill Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: Improved Survival Following Reduced Intensity Conditioning

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only